Invex Therapeutics Ltd. Both approaches can work, but it is not wise to confuse the two. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Learn how it impacts everything we do. Invex Granted Type C Meeting with FDA, page-2. 6 Upvote. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. AX stock on Yahoo Finance. Invex Granted Key European Patent for Exenatide, page-2. ASX - By Stock. ASX - General. ASX - General. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. ASX - Day Trading. Charts. ASX - Short Term Trading. Forums. Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. Market Cap $16. . I think having this out we can discuss on the way. , page-3. Update - Notification regarding unquoted securities - IXC. Cold Comfort Ice Cream Company, Victoria, British Columbia. Invex Granted Type C Meeting with FDA, page-3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Market . Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. com. ASX - Short Term Trading. . Also took placement stock @$1. Update - Notification regarding unquoted securities - IXC. A rolling snowball gathers snow as it falls down the hill . . Created with Sketch. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. 0. ASX - By Stock. Target our investor community with our suite of Hotcopper Advertising opportunities. Advertise on HotCopper. . Most bio's get. Last updated 15. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. . Market open. . Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. This is a complete waste of time and posting space - give yourself a break man and forget about trying to predict what is completely un-predictable. Some people like to gamble on stocks, others invest. ASX - By Stock. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. Trading HaltIXC Valuation Report MST. Latest Posts. Below is the broker data for IXC November to. 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. But posts 3-4 times a day that are the same charts we can all see, about a -3% move on $10k volume, paired with hysteria and paranoia, its just not. . Proposed listing date: 4 JULY 2019#Created with Sketch. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Discover historical prices for IXC. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. I knew zero about the fundamentals of IXC. ASX - By Stock. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Appendix 4C - quarterly* or having a go at doing so, page-30. Join HotCopper today. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Latest Posts. Latest Posts. 5¢ INVEX THERAPEUTICS LTD - Discussion. . ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. Created with Sketch. sentiment based on opinions from HotCopper and others. Probably been disappointed like all of usCreated with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Share IXC needs to be proactive and release a statement. **Close price adjusted for splits and dividend and/or capital gain distributions. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. . Discover historical prices for IXC. 31% more bullish than other Healthcare sector stocks. 20 to $7. ASX - Day TradingI sold around half my shares yesterday at 25c. . , page-2. See page-34. Created with Sketch. Created with Sketch. Created with Sketch. We are a team of expert financial advisers each specialising in different, yet complementary areas. . ASX - Day TradingCreated with Sketch. ASX - Short Term Trading. IXC (ASX) Ann: Trading Halt - HotCopper. International Markets. Market . Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. . Forex. ASX - Day TradingAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Advertise on HotCopper. Initial FDA and EMA Advice on Presendin Development, page-3. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. , page-5. ASX - General. Notice of Annual General Meeting/Proxy Form, page-2. . Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. Invex Therapeutics Lists on ASXNo worries mate :), page-15. My. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. , page-2. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Share Appreciate the commentary and post. Market . Invex issued US patent for Traumatic Brain Injury. . Notification of cessation of securities - IXC. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. IXC Price at posting:. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. , page-2. . ASX - Short Term Trading. Andrew Forrest , or his entities have been involved with IXC since inception. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. 1. Advertise on HotCopper. , page-3. ASX - By Stock. . ASX - Short Term Trading. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. . ASX - By Stock. Sentiment for Invex Therapeutics Ltd. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Created with Sketch. Latest Posts. Join the HotCopper ASX share market forum today for free. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. Last edited by jellyroll: 27/02/23. ASX - By Stock. ASX - General. . If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. Market . . Some people like to gamble on stocks, others invest. IXC Price at posting: $1. 4KB OECCreated with Sketch. , page-5. ASX - Day Trading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC Price at posting: 23. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. Created with Sketch. Charts. . About 90 percent of the U. IXC Price at posting. ASX - Short Term Trading. Forums. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC Valuation Report MST. Charts. AVALANCHE. ASX - By Stock. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Created with Sketch. ASX - By Stock. Andrew Forrest , or his entities have been involved with IXC since inception. Slow and steady with IXC. Created with Sketch. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. ASX - By Stock. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. . ASX - By Stock. ASX - Short Term Trading. 76 (-1. 0% $ODM 35. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. . Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Created with Sketch. Also took placement stock @$1. Join the HotCopper ASX share market forum today for free. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. P3 will be kicked off in early CY2021. When can we expect some update or. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. DJPIN. . A new thread to put trading comments / reasoning / opinions in. . ASX - By Stock. Created with Sketch. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Notice of Investor Call and Presentation, page-3. All IMO IXC Price at posting: 37. ASX - By Stock. 0. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. sentiment based on opinions from HotCopper and others. Invex Therapeutics Lists on ASX, page-3. Strong buy side, sell side still very thin. Market open. 1. . Charts. Appreciate your input Dr T. 91%) As of 03:35PM EST. Share “Exercise Price Subject to paragraph (j), the amount payable upon exercise of each Option will be the 50% premium to the 30 day VWAP immediately prior to the Meeting (Exercise Price). @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. ASX - Day Trading0. I see it at perhaps $5 prior to readout. ASX - General. you post every single trade that is a sell onto Hotcopper. ASX - By Stock. Market . The fact it recovered and closed about the 1. Most bio's get acquired on P2 readouts, if results are strong early here. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. gov and there is lots of good information about the trial. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. Currency in USD 38. . Market . Forums. , page-32. Ceasing to be a substantial holder. International Markets. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. 5¢ Sentiment: Buy Disclosure: Held. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. So your thesis is right on a long time time frame. Latest Posts. Invex Receives Approval for Paediatric Plan from the EMA, page-3. I guess that's why retail performs so poorly on average, so many think they are long term investors but can't hold onto their shares for more. ASX - Day Trading. . , page-4. ASX - By Stock. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. IXC Price at posting: 37. Withdrawal of AGM Resolutions, page-2. IXC Price at posting: 44. Created with. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Invex Receives Approval for Paediatric Plan from the EMA, page-2. We are a team of expert financial advisers each specialising in different, yet complementary areas. Can't see how this doesn't push up soon, page-508. . ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. . Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. . Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. 76 (-1. 0 Great. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. , page-2. , page-3. 64440. Therefore Id bet the same bet with the same info again. Latest Posts. IXC Price at posting: 79. 3¢. 1950. Quarterly Activities/Appendix 4C Cash Flow Report. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. , page-4. Market . Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. , page-6. ASX - By Stock. . Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Created with Sketch. Learn more. ASX - Day Trading. 333334. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - Short Term Trading. , page-4. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Last updated 15. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. ASX - Short Term Trading. . IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. ASX - By Stock. Market . 1950. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Latest Posts. Too many factors to make an educated appraisal of buyout pre-Phase 2 or post Phase 2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Latest Posts. . It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. Report to HotCopper and itll be the end of it, cheers. Invex Therapeutics Ltd. . Created with Sketch. . Charts. 6million shares?, and if so is anyone worried about this, release date 29th. , page-3. Latest Posts. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. 31% more bullish than other Healthcare sector stocks. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Latest Posts. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . 10 cents a week and we will be at $2 plus in no time. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Top 20 remains holding 58% compared to 58. . is 19. Sentiment for Invex Therapeutics Ltd. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Created with Sketch. Charts. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. 91%) As of 03:35PM EST. wonder if the GLP-1 agonist referred to in this media release. Notification of cessation of securities - IXC. Created with Sketch. Created with Sketch. 4. Trading HaltCreated with Sketch. But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Latest Posts. 6% $DLM 50. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 1. ASX - General. Commodities. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Share Not unexpected. Forums. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Join the HotCopper ASX share market forum today. Forums. 1956773. I think IXC has the potential to do better.